Novartis Bucks the Trend

While many drug companies now see development as key to boosting productivity, Novartis is investing heavily in its own discovery capacity. A new research head has been hiring hot shots out of biotech firms and academia, assembling new technologies to complement classical skills. Novartis seems to be striving to be mostly self-dependent. Will the bet pay off?